CARYSIL
|
|
BOM : 524091     NSE : CARYSIL     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Jun 07,2023 |
Price(EOD): βΉ 561.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Household & Personal Products |
MCap: βΉ 1,504.42 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
CARYSIL | 1% | -5% | -3% |
HINDUSTAN UNILEVER | 0.6% | 7.9% | 17.7% |
DABUR INDIA | -0% | 7.4% | 5% |
GODREJ CONSUMER PRODUCTS | 1.2% | 12% | 37.1% |
PROCTER & GAMBLE HYGIENE & HEALTH CARE | 1.3% | 0% | -3.6% |
COLGATEPALMOLIVE (INDIA) | 1.6% | 3.4% | 1.9% |
EMAMI | 1.7% | 3.9% | -6.5% |
GILLETTE INDIA | 0.9% | -3.1% | -8.1% |
SHEELA FOAM | 0.5% | -3.6% | -30.7% |
FUNDAMENTAL ANALYSIS OF CARYSIL
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF CARYSIL
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
28.45
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 52.83 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 4.95
P/B Calculated based on Book Value of Rs 303.38 Cr
[Latest Year - Mar2023 - Consolidated Results ] 2.53
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 593.89 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
21% 39% 55% |
SHARE PRICE MOMENTUM OF CARYSIL
CARYSIL vs SENSEX
DEBT OF CARYSIL
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.62 0.6 0.64 0.62 |
0.55 0.53 0.65 0.58 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF CARYSIL
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF CARYSIL
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
5.64% 4.89% 14.36% 3.06% |
4.78% -6.97% -26.2% -24.41% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
CARYSIL related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE CONSUMER DISC. | 3.5% | 7.7% | 22.3% |
S&P BSE SMALL CAP | 3.3% | 7.1% | 18.8% |
S&P BSE MIDSMALLCAP | 2.9% | 6.7% | 19.4% |
S&P BSE ALLCAP | 1.6% | 3.9% | 13.8% |
You may also like the below Video Courses
FAQ about CARYSIL
Is CARYSIL good for long term investment?
As on Jun 07,2023, the Fundamentals of CARYSIL look Strong and hence it may be good for long term investment! See Financial Performance of CARYSIL . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is CARYSIL UnderValued or OverValued?
As on Jun 07,2023, CARYSIL is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of CARYSIL ?
As on Jun 07,2023, the Intrinsic Value of CARYSIL is Rs. 405.12 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 463.36
Fair Value [Median EV / Sales Model] : Rs. 405.12
Fair Value [Median Price / Sales Model] : Rs. 362.29
Estimated Median Fair Value of CARYSIL : Rs. 405.12
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is CARYSIL trading at a Premium or Discount?
As on Jun 07,2023, CARYSIL is trading at a Premium of 39% based on the estimates of Median Intrinsic Value!